REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 57 filers reported holding REPLIMUNE GROUP INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $4,505,000 | -43.1% | 313,922 | -44.9% | 2.52% | -16.5% |
Q3 2019 | $7,918,000 | -30.7% | 569,662 | -26.9% | 3.02% | -19.3% |
Q2 2019 | $11,430,000 | -3.7% | 779,656 | +4.0% | 3.75% | +21.3% |
Q1 2019 | $11,866,000 | +52.2% | 749,654 | -3.8% | 3.09% | +20.6% |
Q4 2018 | $7,797,000 | -37.9% | 779,656 | 0.0% | 2.56% | -7.5% |
Q3 2018 | $12,552,000 | – | 779,656 | – | 2.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |